Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
May 27, 2026, 3:39 PM EST
Syros Pharmaceuticals Market Cap
Syros Pharmaceuticals has a market cap or net worth of $5.37 thousand as of May 27, 2026. Its market cap has decreased by -99.49% in one year.
Market Cap
5.37K
Enterprise Value
n/a
Revenue
386.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 30, 2016, Syros Pharmaceuticals's market cap has decreased from 413.10M to 5.37K, a decrease of -100.00%. That is a compound annual growth rate of -67.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 10.73K | 14.29% |
| Dec 31, 2025 | 9.39K | -99.85% |
| Dec 31, 2024 | 6.17M | -96.96% |
| Dec 29, 2023 | 202.59M | 179.01% |
| Dec 30, 2022 | 72.61M | -64.04% |
| Dec 31, 2021 | 201.95M | -59.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scopus BioPharma | 16.83K |
| Regenicin | 15.35K |
| Vaxxinity | 12.68K |
| ObsEva | 11.72K |
| Biostax | 10.77K |
| Trevena | 10.64K |
| GeneLink | 10.60K |
| Bioasis Technologies | 7.94K |